639 related articles for article (PubMed ID: 31863779)
21. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
[TBL] [Abstract][Full Text] [Related]
22. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
Zhang Y; Xu Y; Ma J; Pang X; Dong M
Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.
Han JY; Oh SH; Morgillo F; Myers JN; Kim E; Hong WK; Lee HY
J Natl Cancer Inst; 2005 Sep; 97(17):1272-86. PubMed ID: 16145048
[TBL] [Abstract][Full Text] [Related]
24. The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.
Park MS; Kim BR; Dong SM; Lee SH; Kim DY; Rho SB
Oncotarget; 2014 Jul; 5(13):4935-44. PubMed ID: 24952732
[TBL] [Abstract][Full Text] [Related]
25. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
26. Diosgenin inhibits tumor angiogenesis through regulating GRP78-mediated HIF-1α and VEGF/VEGFR signaling pathways.
Cai H; Gong L; Liu J; Zhou Q; Zheng Z
Pharmazie; 2019 Nov; 74(11):680-684. PubMed ID: 31739837
[TBL] [Abstract][Full Text] [Related]
27. Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo.
Dewangan J; Srivastava S; Mishra S; Divakar A; Kumar S; Rath SK
Biochem Pharmacol; 2019 Jun; 164():326-335. PubMed ID: 31028743
[TBL] [Abstract][Full Text] [Related]
28. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
29. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
[TBL] [Abstract][Full Text] [Related]
30. Salidroside improves angiogenesis-osteogenesis coupling by regulating the HIF-1α/VEGF signalling pathway in the bone environment.
Guo Q; Yang J; Chen Y; Jin X; Li Z; Wen X; Xia Q; Wang Y
Eur J Pharmacol; 2020 Oct; 884():173394. PubMed ID: 32730833
[TBL] [Abstract][Full Text] [Related]
31. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
[TBL] [Abstract][Full Text] [Related]
32. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways.
Pratheeshkumar P; Budhraja A; Son YO; Wang X; Zhang Z; Ding S; Wang L; Hitron A; Lee JC; Xu M; Chen G; Luo J; Shi X
PLoS One; 2012; 7(10):e47516. PubMed ID: 23094058
[TBL] [Abstract][Full Text] [Related]
33. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression.
Fang J; Zhou Q; Liu LZ; Xia C; Hu X; Shi X; Jiang BH
Carcinogenesis; 2007 Apr; 28(4):858-64. PubMed ID: 17071632
[TBL] [Abstract][Full Text] [Related]
34. Nuclear factor 90 promotes angiogenesis by regulating HIF-1α/VEGF-A expression through the PI3K/Akt signaling pathway in human cervical cancer.
Zhang W; Xiong Z; Wei T; Li Q; Tan Y; Ling L; Feng X
Cell Death Dis; 2018 Feb; 9(3):276. PubMed ID: 29449553
[TBL] [Abstract][Full Text] [Related]
35. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
[TBL] [Abstract][Full Text] [Related]
36. SYP-5, a novel HIF-1 inhibitor, suppresses tumor cells invasion and angiogenesis.
Wang LH; Jiang XR; Yang JY; Bao XF; Chen JL; Liu X; Chen GL; Wu CF
Eur J Pharmacol; 2016 Nov; 791():560-568. PubMed ID: 27664769
[TBL] [Abstract][Full Text] [Related]
37. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
38. Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells.
Das B; Dash SR; Patel H; Sinha S; Bhal S; Paul S; Das C; Pradhan R; Ahmed I; Goutam K; Kundu CN
Phytomedicine; 2023 Aug; 117():154914. PubMed ID: 37321076
[TBL] [Abstract][Full Text] [Related]
39. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
[TBL] [Abstract][Full Text] [Related]
40. Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model.
Nam S; Kim H; Hong D; Park JB; Kim SJ
Anticancer Res; 2017 Nov; 37(11):6291-6302. PubMed ID: 29061812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
